Pulsus Group will invest Rs 500 crore to expand its AI healthcare and digital innovation hub in Telangana, creating 6,000 direct and 30,000...

A Chinese-linked hacking group secretly stole data from U.S. and Canadian academic, medical, and military research institutions. The cybere...

India first: Firms prioritise domestic industry guidelines over global frameworks, remain confident on DPDP

Indian companies are prioritising local AI rules over international ones. They are focusing on ethics, identity, and privacy as AI adoption...

A new drug for Alzheimer's, donanemab, has arrived in India. It aims to slow the disease's progression by clearing brain plaques. While off...

Elon Musk, the world's richest man, leads a sprawling business empire. His ventures include electric vehicles, brain implants, underground ...

With an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The com...

The Personal Information Protection Commission said the New York-listed company had leaked personal data of more than 33 million customers ...

Precision oncology startup 4baseCare has raised Rs 128 crore. This funding will expand its genomics labs globally and scale its AI platform...

The Calcutta High Court has provided interim protection to former West Bengal sports minister Aroop Biswas. This comes in a case concerning...

India's anti-obesity drug market sees a slowdown after initial generic semaglutide sales. Demand has eased from its peak, with growth moder...

Elon Musk brain chip Neuralink competitor: China has approved the world's first brain-computer chip, NEO, for commercial sale after complet...

Originally developed to address eye disorders such as blepharospasm, Botox has evolved into a key player in the cosmetic industry since its...

A groundbreaking vaccine, designed entirely by artificial intelligence, has been tested in humans for the first time. This experimental jab...

CEPI is investing around $60 million to speed up the creation of vaccines against the deadly Ebola Bundibugyo virus. This funding will supp...

Toregem BioPharma has secured $5.3 million to advance its experimental tooth-regeneration drug, TRG035, into Phase II clinical trials. The ...

A rare Bundibugyo virus outbreak in Congo, with over 200 deaths, lacks specific treatments or vaccines, complicating response efforts. Whil...